Hashimoto T - Search Results

1

Effect of Canagliflozin on Urinary Albumin Excretion in Japanese Patients with Type 2 Diabetes Mellitus and Microalbuminuria: A Pilot Study.

Osonoi T, Gouda M, Kubo M, Arakawa K, Hashimoto T, Abe M. Osonoi T, et al. Among authors: hashimoto t. Diabetes Technol Ther. 2018 Oct;20(10):681-688. doi: 10.1089/dia.2018.0169. Epub 2018 Aug 10. Diabetes Technol Ther. 2018. PMID: 30096243 Free PMC article. Clinical Trial.

2

Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus.

Tanaka H, Takano K, Iijima H, Kubo H, Maruyama N, Hashimoto T, Arakawa K, Togo M, Inagaki N, Kaku K. Tanaka H, et al. Among authors: hashimoto t. Adv Ther. 2017 Feb;34(2):436-451. doi: 10.1007/s12325-016-0457-8. Epub 2016 Dec 15. Adv Ther. 2017. PMID: 27981497 Free PMC article. Clinical Trial.

3

Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes.

Takahara M, Shiraiwa T, Matsuoka TA, Yamamoto K, Maeno Y, Shiraiwa Y, Yoshida Y, Katakami N, Iijima H, Katsumata H, Arakawa K, Hashimoto T, Shimomura I. Takahara M, et al. Among authors: hashimoto t. Diabetes Metab Syndr Obes. 2020 Nov 18;13:4457-4468. doi: 10.2147/DMSO.S273396. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 33244248 Free PMC article.

4

Effects of canagliflozin, an SGLT2 inhibitor, on hepatic function in Japanese patients with type 2 diabetes mellitus: pooled and subgroup analyses of clinical trials.

Seko Y, Sumida Y, Sasaki K, Itoh Y, Iijima H, Hashimoto T, Ishii S, Inagaki N. Seko Y, et al. Among authors: hashimoto t. J Gastroenterol. 2018 Jan;53(1):140-151. doi: 10.1007/s00535-017-1364-8. Epub 2017 Jul 1. J Gastroenterol. 2018. PMID: 28669071

5

Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1-3 fibrosis.

Seko Y, Nishikawa T, Umemura A, Yamaguchi K, Moriguchi M, Yasui K, Kimura M, Iijima H, Hashimoto T, Sumida Y, Okanoue T, Itoh Y. Seko Y, et al. Among authors: hashimoto t. Diabetes Metab Syndr Obes. 2018 Nov 27;11:835-843. doi: 10.2147/DMSO.S184767. eCollection 2018. Diabetes Metab Syndr Obes. 2018. PMID: 30568471 Free PMC article.

6

Hemostatic action of OC-108, a novel agent for hemorrhoids, is associated with regional blood flow arrest induced by acute inflammation.

Ono T, Nakagawa H, Fukunari A, Hashimoto T, Komatsu H. Ono T, et al. Among authors: hashimoto t. J Pharmacol Sci. 2006 Nov;102(3):314-20. doi: 10.1254/jphs.fp0060583. Epub 2006 Oct 28. J Pharmacol Sci. 2006. PMID: 17072100 Free article.

7

Composition templating for heterogeneous nucleation of intermetallic compounds.

Que Z, Wang Y, Fan Z, Hashimoto T, Zhou XR. Que Z, et al. Among authors: hashimoto t. Sci Rep. 2024 Apr 18;14(1):8968. doi: 10.1038/s41598-024-59709-w. Sci Rep. 2024. PMID: 38637679

8

Effects of different exercise intensities or durations on salivary IgA secretion.

Uchino T, Uchida M, Ito R, Fujie S, Iemitsu K, Kojima C, Nakamura M, Shimizu K, Tanimura Y, Shinohara Y, Hashimoto T, Isaka T, Iemitsu M. Uchino T, et al. Among authors: hashimoto t. Eur J Appl Physiol. 2024 Apr 18. doi: 10.1007/s00421-024-05467-6. Online ahead of print. Eur J Appl Physiol. 2024. PMID: 38634902

9

Potential correlation between anti-laminin 332 autoantibodies and malignant tumours in anti-BP180-type mucous membrane pemphigoid.

Li X, Pas HH, Qian H, Rashid H, Horvath B, Yilmaz K, van Beek N, Schmidt E, Zillikens D, Ishii N, Tsuruta D, Hashimoto T. Li X, et al. Among authors: hashimoto t. Clin Exp Dermatol. 2024 Apr 18:llae124. doi: 10.1093/ced/llae124. Online ahead of print. Clin Exp Dermatol. 2024. PMID: 38634807 No abstract available.

10

The therapeutic effect of proteinase-activated receptor-1 antagonist on colitis-associated carcinogenesis.

Li X, Kurahara LH, Zhao Z, Zhao F, Ishikawa R, Ohmichi K, Li G, Yamashita T, Hashimoto T, Hirano M, Sun Z, Hirano K. Li X, et al. Among authors: hashimoto t. Cell Mol Gastroenterol Hepatol. 2024 Apr 11:S2352-345X(24)00071-7. doi: 10.1016/j.jcmgh.2024.04.001. Online ahead of print. Cell Mol Gastroenterol Hepatol. 2024. PMID: 38614455 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,881 results

Search Page